Inovio Pharmaceuticals, Inc. (formerly Inovio Biomedical Corporation)
Profile
Mailing Address: 11494 Sorrento Valley Road, Suite A
San Diego, California
92121-1318
Head Office Address: 1787 Sentry Parkway West, Suite A
Building 18, Suite 400
Blue Bell,, PA
19422
Contact Name: Peter Kies Principal Regulator: British Columbia
Business e-mail address: cha@inovio.com Short Form Prospectus Issuer: No
Telephone Number: 858 410-3149 Reporting Jurisdictions: British Columbia, Ontario
Fax Number: 858 597-0451 Stock Exchange: NYSE, AMEX
Date of Formation: Aug 8 1979 Stock Symbol: INO
Jurisdiction Where Formed: Delaware Auditor: Ernst & Young
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 371916 Transfer Agent: Computershare Trust Company of Canada
Financial Year-End: Dec 31 Size of Issuer (Assets): $5,000,001 to $25,000,000


View This Company's Documents